Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 15, 2025

INmune Bio, CGT Catapult to set up manufacturing for cell therapy platforms

INmune Bio has collaborated with the Cell and Gene Therapy Catapult (CGT Catapult) to set up large-scale manufacturing for its cell therapy platforms.

Continue
The collaboration is expected to expedite INmune Bio's path to commercialisation by providing scalable manufacturing while maintaining operational control. Credit: Hans Reniers on Unsplash.
April 14, 2025

Nona Biosciences and Atossa team up to discover breast cancer therapies

To date, the Harbour Mice platform has been utilised in over 250 drug discovery programmes across various therapeutic areas. Credit: National Cancer Institute by Unsplash.
April 11, 2025

Imbria secures $57.5m to advance ninerafaxstat through Phase IIb nHCM trial

The therapy has demonstrated encouraging outcomes in Phase IIa trials for nHCM and heart failure with preserved ejection fraction. Credit: jesse orrico on Unsplash.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Renovaro closes merger transaction with BioSymetrics
  2. France 2030 funds 4MB’s knee osteoarthritis drug trial
  3. ALX Oncology’s ALX2004 gains FDA IND clearance to treat solid tumours
  4. FDA grants breakthrough therapy status for Amgen’s Uplizna to treat IgG4-RD
  5. FDA clears Epicrispr’s application for FSHD treatment

PRESS RELEASES

LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships
LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Two Stories, One Future: Gerresheimer and Bormioli Pharma at Pharmapack 2025
Two Stories, One Future: Gerresheimer and Bormioli Pharma at Pharmapack 2025
Gerresheimer Successfully Completes Acquisition of Blitz LuxCo, the Holding Company of the Bormioli Pharma Group
Gerresheimer Successfully Completes Acquisition of Blitz LuxCo, the Holding Company of the Bormioli Pharma Group
Gerresheimer Builds New Production Capacities for Glass Syringes at Skopje Site
Gerresheimer Builds New Production Capacities for Glass Syringes at Skopje Site

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation